4.7 Review

Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway

Hang Yin et al.

Summary: This study reveals that m6A RNA methylation-mediated RMRP stability promotes proliferation and progression of non-small cell lung cancer through regulating the TGFBR1/SMAD2/SMAD3 pathway.

CELL DEATH AND DIFFERENTIATION (2023)

Article Dentistry, Oral Surgery & Medicine

Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38

Ting Xu et al.

Summary: METTL3, a methyltransferase, plays a crucial role in the regulation of tumorigenesis in OSCC.

ORAL DISEASES (2023)

Article Cell Biology

YTHDC2 control of gametogenesis requires helicase activity but not m6A binding

Yuhki Saito et al.

Summary: In this study, the researchers investigated how the N-6-methyladenosine (m(6)A) reader and RNA helicase YTHDC2 regulate gene expression during meiosis. They found that YTHDC2 can bind transcripts independent of m(6)A status and regulate gene expression through distinct mechanisms during multiple stages of meiosis. Mutation of the m(6)A-binding pocket of YTHDC2 had no effect on gametogenesis, suggesting that YTHDC2's function is m(6)A-independent. However, mutation in the ATPase motif of YTHDC2 blocked meiotic prophase I progression, causing sterility.

GENES & DEVELOPMENT (2022)

Review Cell Biology

RNA methyltransferase METTL16: Targets and function

Emily R. Satterwhite et al.

Summary: METTL16 is an emerging player in the RNA modification landscape, with multiple RNA interactors and a key role in regulating gene expression through methylation. Its mechanisms and biological functions in the cell are still being explored.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2022)

Article Biotechnology & Applied Microbiology

Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer

Xiaofang He et al.

Summary: This study revealed that the expression pattern of m(6)A regulators in breast cancer is significantly correlated with RNA methylation modification, overall survival, PI3K/AKT and KRAS signaling, angiogenesis, and antitumor immune response. These findings suggest that m(6)A regulators could serve as potential targets and biomarkers for immunotherapy in breast cancer.

CANCER GENE THERAPY (2021)

Article Oncology

YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7

Jingnan Pi et al.

Summary: This study reveals the oncogenic role of YTHDF1 in gastric cancer, showing its regulation of the Wnt/β-catenin signaling pathway through m(6)A modification. Inhibition of YTHDF1 can reduce gastric cancer cell proliferation and tumorigenesis, suggesting a new approach for targeting epigenetic regulators in cancer treatment.

CANCER RESEARCH (2021)

Article Hematology

piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL

Huiying Han et al.

Summary: The study demonstrates that piRNA-30473 plays an oncogenic role in promoting the aggressive phenotype of DLBCL, and its depletion can reduce proliferation and induce cell cycle arrest. Through regulating m6A RNA methylation, the piRNA-30473/WTAP/HK2 axis contributes to the progression of DLBCL.

BLOOD (2021)

Article Cell Biology

ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma

Lili Hao et al.

Summary: The study revealed that high expression of ALKBH5 is associated with poor outcome in uveal melanoma. ALKBH5 promotes UM progression by demethylating FOXM1 mRNA, potentially inducing EMT for cell metastasis.

AGING-US (2021)

Article Oncology

ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment

Feng Dong et al.

Summary: This study reveals that hypoxia-induced upregulation of m(6)A demethylase ALKBH5 leads to the formation of NEAT1-mediated paraspeckles, resulting in increased CXCL8/IL8 expression and enhanced TAM recruitment and tumor progression in GBM. The findings provide evidence for the link between hypoxia-induced epitranscriptomic changes and the formation of an immunosuppressive microenvironment.

CANCER RESEARCH (2021)

Article Cell Biology

HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α

Nanmu Yang et al.

Summary: HBXIP drives metabolic reprogramming in HCC cells via METTL3-mediated m6A modification of HIF-1 alpha.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Biochemistry & Molecular Biology

R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis

Ying Qing et al.

Summary: R-2-hydroxyglutarate (R-2HG) inhibits aerobic glycolysis in leukemia cells by targeting RNA modification, highlighting the therapeutic potential of targeting cancer epitranscriptomics and metabolism. This study reveals previously unrecognized effects of R-2HG on leukemia cells, providing insights into novel treatments for cancer.

MOLECULAR CELL (2021)

Article Biochemistry & Molecular Biology

A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability

Pengpeng Zhu et al.

Summary: In a hypoxic microenvironment, a long noncoding RNA called KB-1980E6.3 was found to be upregulated in breast cancer tissues, promoting self-renewal of breast cancer stem cells and tumorigenesis. It exerts its function through the lncRNA KB-1980E6.3/IGF2BP1/c-Myc signaling axis, maintaining stemness.

ONCOGENE (2021)

Article Oncology

N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma

Shen Shen et al.

Summary: This study identified three different m6A modification subtypes in hepatocellular carcinoma (HCC) patients, which were associated with different immune cell infiltration phenotypes in the tumor immune microenvironment (TIME). Low expression of METTL3 was correlated with increased infiltration of dendritic cells (DCs) in the TIME, and patients with low m6A scores had better overall survival and 5-year survival rates.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Gastroenterology & Hepatology

RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target

Huarong Chen et al.

Summary: The study revealed that the m(6)A regulatory enzyme METTL3 is upregulated in colorectal cancer (CRC) and predicts poor survival in patients. Inhibition of METTL3 suppresses tumorigenesis in CRC cells and organoids. METTL3 promotes CRC development by activating the m(6)A-GLUT1-mTORC1 axis.

GASTROENTEROLOGY (2021)

Article Oncology

LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification

Pingfu Hou et al.

Summary: The study found that LINC00460 is upregulated in CRC and high expression is associated with poor survival rates. LINC00460 interacts with IGF2BP2 and DHX9 to enhance the stability of HMGA1 mRNA through m6A modification, promoting cell proliferation, migration, and invasion in CRC.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming

Huilong Yin et al.

Summary: The study reveals that deletion of Mettl3 in myeloid cells promotes tumor growth and metastasis, as well as affecting the efficacy of PD-1 checkpoint blockade therapy.

NATURE COMMUNICATIONS (2021)

Article Medicine, Research & Experimental

METTL3-mediatedm6Amodification ofZBTB4mRNA is involved in the smoking-induced EMT in cancer of the lung

Cheng Cheng et al.

Summary: N6-methyladenosine (m(6)A) modification of ZBTB4 via EZH2, mediated by METTL3, is involved in cigarette smoke-induced epithelial-mesenchymal transition (EMT) and lung cancer. The higher expression of METTL3 in lung tissues of smokers is inversely correlated with ZBTB4 levels. These findings suggest that m(6)A modifications could be a potential therapeutic target for lung damage induced by cigarette smoke.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Oncology

Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic

Amit Grover et al.

Summary: MDSCs are important regulators of immune responses in cancer, and their association with negative clinical outcomes makes them attractive therapeutic targets. However, the complex nature of MDSC biology presents a substantial challenge for therapeutic targeting. This review discusses the challenges and potential solutions in targeting MDSCs for therapeutic intervention.

CANCER DISCOVERY (2021)

Article Biotechnology & Applied Microbiology

Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer

Xuyang Liang et al.

Summary: METTL3 is highly expressed in esophageal cancer patients and associated with severe lymph node involvement and distant metastasis. Downregulation of METTL3 inhibits invasiveness, migration, and EMT. METTL3 elevates miR-20a-5p expression via improving m6A modification.

BIOENGINEERED (2021)

Article Oncology

Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway

Xiaofeng Liu et al.

Summary: In this study, Sec62 was identified as a novel chemoresistance-related target in colorectal cancer, with upregulation associated with poor patient outcomes. Sec62 was found to promote stemness in CRC cells through activating the Wnt signaling pathway. This study provides insights into potential therapeutic targets for improving treatment outcomes in colorectal cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Cell Biology

m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability

Hongjiang Liu et al.

Summary: The study revealed that in glioblastoma multiforme, the m(6)A modification is associated with elevated expression of lncRNA CASC9, which cooperates with IGF2BP2 to promote aerobic glycolysis.

CELL DEATH DISCOVERY (2021)

Article Multidisciplinary Sciences

Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Eliza Yankova et al.

Summary: The study identified a highly potent and selective catalytic inhibitor of METTL3, STM2457, which shows potential therapeutic value in treating AML. Treatment with this inhibitor leads to reduced AML growth, increased differentiation and apoptosis, and decreased m(6)A levels on leukemogenic mRNAs. In vivo pharmacological inhibition of METTL3 results in impaired engraftment and prolonged survival in mouse models of AML.

NATURE (2021)

Article Cell Biology

RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/β-catenin signaling

Yin Li et al.

Summary: The study revealed that YTHDF2 is significantly upregulated in LUAD, and its interference affects the growth, colony formation, and migration of LUAD cells by promoting AXIN1 mRNA decay and subsequently activating the Wnt/beta-catenin signaling pathway.

CELL DEATH & DISEASE (2021)

Review Oncology

The Next Decade of Immune Checkpoint Therapy

Padmanee Sharma et al.

Summary: Immune checkpoint therapy can provide durable antitumor responses for subsets of cancer patients, but challenges remain in understanding resistance mechanisms, optimizing patient selection, managing immune-related adverse events, and identifying rational therapeutic combinations. A focused approach encompassing clinical and basic research with integration of reverse translational studies is needed to address these challenges and guide the development of novel combination strategies.

CANCER DISCOVERY (2021)

Article Chemistry, Multidisciplinary

The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ

Xia Wang et al.

Summary: The protein IGF2BP2 plays a key role in regulating the transition of macrophages from M1 to M2 phenotype, suggesting it as a potential therapeutic target for inflammatory diseases.

ADVANCED SCIENCE (2021)

Article Biochemistry & Molecular Biology

Streptozotocin-Induced Astrocyte Mitochondrial Dysfunction Is Ameliorated by FTO Inhibitor MO-I-500

Zuzana Cockova et al.

Summary: This study investigates the potential role of m6A machinery enzymes in Alzheimer's disease, suggesting that perturbed m6A signaling may contribute to the pathogenesis of AD by compromising astrocyte bioenergetics. Results show that inhibition of FTO can reduce adverse effects of STZ and protect cells from oxidative stress, apoptosis, and other disturbances induced by the compound, providing insights into potential therapeutic targets for AD.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Oncology

Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma

Lianzi Wang et al.

Summary: The study revealed upregulation of m6A RNA methylation modulators in pancreatic cancer patients, and established an m6Ascore prognosis model as an indicator of patient prognosis. High m6Ascore was closely associated with immune cell infiltration, but further research is needed to determine its effectiveness in predicting patient response to immunotherapy.

BMC CANCER (2021)

Article Oncology

The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth

Lihui Dong et al.

Summary: The study reveals that the m(6)A methyltransferase Mettl14 in TAMs plays a role in modulating the function of CD8(+) T cells by regulating C1q(+) TAMs, ultimately affecting tumor progression.

CANCER CELL (2021)

Article Oncology

The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis

Chengpeng Zhao et al.

Summary: This study revealed that METTL3 promotes epithelial-mesenchymal transition in breast cancer via the MALAT1/miR-26b/HMGA2 axis, while miR-26b levels were low in BC. MALAT1 promotes HMGA2 expression by sponging miR-26b, leading to EMT, migration, and invasion in BC cells.

CANCER CELL INTERNATIONAL (2021)

Article Oncology

M(6)A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma

Xinyao Qiu et al.

Summary: This study identifies PD-L1 mRNA as a target of ALKBH5 and reveals a role for ALKBH5 in regulating the tumor immune microenvironment and immunotherapy efficacy. These findings suggest a new regulatory mechanism for PD-L1 involving mRNA epigenetic modification by ALKBH5, as well as a potential role for ALKBH5 in cancer immunotherapies.

CANCER RESEARCH (2021)

Article Oncology

被撤回的出版物: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2 (Retracted article. See vol. 42, 2023)

Guizhi Jia et al.

Summary: This study identified the upregulation of LNCAROD in HCC patients, predicting a poor prognosis, and revealed that LNCAROD promotes HCC progression through PKM2-mediated glycolysis enhancement. The molecular mechanism involves the interaction with different factors and sponging miR-145-5p to maintain PKM2 levels, especially under hypoxic conditions, providing a potential diagnostic marker and therapeutic target for HCC patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Cell & Tissue Engineering

IGF2BP1 Promotes the Liver Cancer Stem Cell Phenotype by Regulating MGAT5 mRNA Stability by m6A RNA Methylation

Yichun Yang et al.

Summary: This study elucidated the mechanism of action of IGF2BP1 on the phenotype of liver cancer stem cells (LCSCs). IGF2BP1 was found to promote self-renewal and chemoresistance in human LCSCs, enhance tumorigenesis in mice, and increase the expression of stemness genes in LCSCs. The study concluded that IGF2BP1 facilitated LCSC phenotypes by promoting the stability of MGAT5 mRNA through m6A modification.

STEM CELLS AND DEVELOPMENT (2021)

Article Multidisciplinary Sciences

METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding

Wei Wang et al.

Summary: This study demonstrates that METTL3 downregulates APC by upregulating its m(6)A modification and recruiting YTHDF2 for APC mRNA degradation, leading to enhanced glycolysis and tumor growth in esophageal cancer.

NATURE COMMUNICATIONS (2021)

Article Medicine, Research & Experimental

m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression

Dawei Rong et al.

Summary: m6A-modified circRNA circHPS5 plays a crucial role in HCC development by regulating phenotype and signaling pathways, impacting the growth and metastasis of HCC cells and affecting patient prognosis.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Cell Biology

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1

Yue Shi et al.

Summary: The study identified that METTL3 promotes ccRCC progression through m(6)A modification-mediated translation of ABCD1.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway

Hao Wu et al.

Summary: The study found that the up-regulation of UCK2 in melanoma may play a crucial role and be associated with poor survival. The m(6)A modification regulated by METTL3 leads to increased mRNA stability of UCK2 in melanoma cancer. Functional and mechanistic experiments indicate that UCK2 enhances the metastasis of melanoma cancer cells through the WNT/β-catenin pathway.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Medicine, Research & Experimental

N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization

Chen Chen et al.

Summary: A novel circRNA, circ1662, was found to be highly expressed in CRC tissues and correlated with poor prognosis and tumor depth. Functionally, circ1662 promoted CRC cell invasion and migration by controlling EMT and accelerating YAP1 nuclear accumulation to regulate the SMAD3 pathway.METTL3 induced circ1662 expression and played a role in CRC metastasis.

THERANOSTICS (2021)

Review Immunology

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Filippo Veglia et al.

Summary: MDSCs are pathologically activated cells with potent immunosuppressive activity, closely associated with poor clinical outcomes in diseases like cancer. Recent studies have identified key distinctions between MDSCs and classical neutrophils and monocytes, providing new insights into therapeutic targeting for cancer and autoimmune diseases through understanding their genomic and metabolic characteristics. Emerging data also suggest potential involvement of MDSCs in pregnancy, neonatal biology, and COVID-19.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader

Xiaoge Hu et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Multidisciplinary Sciences

N6-methyladenosine regulates glycolysis of cancer cells through PDK4

Zihan Li et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

m6A-dependent glycolysis enhances colorectal cancer progression

Chaoqin Shen et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA

Sara Zaccara et al.

Article Medicine, Research & Experimental

UpregulatedMETTL3in nasopharyngeal carcinoma enhances the motility of cancer cells

Zhi-Feng Liu et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells

Nobuhiro Tsuruta et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment

Na Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Medicine, Research & Experimental

Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer

Huan-he Ni et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Article Medicine, Research & Experimental

YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner

Xiangxiang Liu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Cell Biology

Context-dependent functional compensation between Ythdf m(6)A reader proteins

Lior Lasman et al.

GENES & DEVELOPMENT (2020)

Review Immunology

Dendritic cells in cancer immunology and immunotherapy

Stefanie K. Wculek et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Oncology

The Critical Role of RNA m6A Methylation in Cancer

Qing Lan et al.

CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

FTO controls reversible m6Am RNA methylation during snRNA biogenesis

Jan Mauer et al.

NATURE CHEMICAL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

RNA structure maps across mammalian cellular compartments

Lei Sun et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

Article Biochemistry & Molecular Biology

METTL3 mediated m6A modification plays an oncogenic role in cutaneous squamous cell carcinoma by regulating ΔNp63

Renpeng Zhou et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

Deciphering the m6A Code via Antibody-Independent Quantitative Profiling

Miguel Angel Garcia-Campos et al.

Article Biochemistry & Molecular Biology

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma

Ting Li et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome

Konstantinos Boulias et al.

MOLECULAR CELL (2019)

Article Multidisciplinary Sciences

m6A enhances the phase separation potential of mRNA

Ryan J. Ries et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112

Nhan Van Tran et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Multidisciplinary Sciences

m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade

Seungwon Yang et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1

Wujun Miao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Review Cell Biology

Reading, writing and erasing mRNA methylation

Sara Zaccara et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Genetics & Heredity

Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly

Elodie M. Richard et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2019)

Article Biochemistry & Molecular Biology

N-6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation

Honghui Ma et al.

NATURE CHEMICAL BIOLOGY (2019)

Review Cell Biology

New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer

Anushka Dongre et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Multidisciplinary Sciences

Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase

Shinichiro Akichika et al.

SCIENCE (2019)

Article Biochemistry & Molecular Biology

N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1

Hongsheng Wang et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma

Li Liu et al.

MOLECULAR CANCER (2019)

Article Multidisciplinary Sciences

Atlas of quantitative single-base-resolution N6-methyl-adenine methylomes

Casslynn W. Q. Koh et al.

NATURE COMMUNICATIONS (2019)

Review Cell Biology

Reading, writing and erasing mRNA methylation

Sara Zaccara et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Rui Su et al.

Letter Cell Biology

m6A mRNA methylation sustains Treg suppressive functions

Jiyu Tong et al.

CELL RESEARCH (2018)

Article Biochemistry & Molecular Biology

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments

Kevin C. Barry et al.

NATURE MEDICINE (2018)

Review Cell Biology

Reading m6A in the Transcriptome: m6A-Binding Proteins

Deepak P. Patil et al.

TRENDS IN CELL BIOLOGY (2018)

Article Multidisciplinary Sciences

Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1

Baixing Wu et al.

NATURE COMMUNICATIONS (2018)

Review Oncology

The role of cancer stem cells in the modulation of anti-tumor immune responses

Cristina Maccalli et al.

SEMINARS IN CANCER BIOLOGY (2018)

Article Multidisciplinary Sciences

Reversible methylation of m6Am in the 5′ cap controls mRNA stability

Jan Mauer et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing

Marek Bartosovic et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Biochemistry & Molecular Biology

N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein

Nian Liu et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Multidisciplinary Sciences

AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells

Yuko Ueda et al.

SCIENTIFIC REPORTS (2017)

Letter Cell Biology

Cytoplasmic m6A reader YTHDF3 promotes mRNA translation

Ang Li et al.

CELL RESEARCH (2017)

Article Biochemistry & Molecular Biology

Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing

Wen Xiao et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex

Xiang Wang et al.

NATURE (2016)

Article Multidisciplinary Sciences

Sleep deprivation and false confessions

Steven J. Frenda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Biochemistry & Molecular Biology

5′ UTR m6A Promotes Cap-Independent Translation

Kate D. Meyer et al.

Article Biochemistry & Molecular Biology

HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events

Claudio R. Alarcon et al.

Article Biochemistry & Molecular Biology

N6-methyladenosine Modulates Messenger RNA Translation Efficiency

Xiao Wang et al.

Article Biochemistry & Molecular Biology

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity

Santiago Zelenay et al.

Article Multidisciplinary Sciences

N6-methyladenosine marks primary microRNAs for processing

Claudio R. Alarcon et al.

NATURE (2015)

Article Multidisciplinary Sciences

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

Stefani Spranger et al.

NATURE (2015)

Article Biochemical Research Methods

Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome

Bastian Linder et al.

NATURE METHODS (2015)

Article Biochemistry & Molecular Biology

Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5

Yue Huang et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemistry & Molecular Biology

Synthesis of a FTO Inhibitor with Anticonvulsant Activity

Guanqun Zheng et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Article Biochemistry & Molecular Biology

Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition

Chong Feng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

N6-methyladenosine-dependent regulation of messenger RNA stability

Xiao Wang et al.

NATURE (2014)

Article Biochemistry & Molecular Biology

Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA

Dominik Theler et al.

NUCLEIC ACIDS RESEARCH (2014)

Review Medicine, Research & Experimental

Targeting lactate metabolism for cancer therapeutics

Joanne R. Doherty et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Oncology

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?

Stephen Yiu Chuen Choi et al.

JOURNAL OF PATHOLOGY (2013)

Review Oncology

MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells

Patrizia Leone et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Article Biochemistry & Molecular Biology

ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility

Guanqun Zheng et al.

MOLECULAR CELL (2013)

Article Chemistry, Multidisciplinary

Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor

Baoen Chen et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Article Multidisciplinary Sciences

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

Dan Dominissini et al.

NATURE (2012)

Review Pharmacology & Pharmacy

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

Gregg L. Semenza

TRENDS IN PHARMACOLOGICAL SCIENCES (2012)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Article Biochemistry & Molecular Biology

Sec22b Regulates Phagosomal Maturation and Antigen Crosspresentation by Dendritic Cells

Ignacio Cebrian et al.

Article Biochemistry & Molecular Biology

N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

Guifang Jia et al.

NATURE CHEMICAL BIOLOGY (2011)

Review Oncology

Otto Warburg's contributions to current concepts of cancer metabolism

Willem H. Koppenol et al.

NATURE REVIEWS CANCER (2011)

Article Cell Biology

ZBP1 recognition of β-actin zipcode induces RNA looping

Jeffrey A. Chao et al.

GENES & DEVELOPMENT (2010)

Article Biochemistry & Molecular Biology

The YTH Domain Is a Novel RNA Binding Domain

Zhaiyi Zhang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Plant Sciences

Anti-angiogenic effects of rhubarb and its anthraquinone derivatives

Zhi-Heng He et al.

JOURNAL OF ETHNOPHARMACOLOGY (2009)

Review Immunology

How regulatory T cells work

Dario A. A. Vignali et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Biochemistry & Molecular Biology

Novel in vivo targets of ΔNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach

Barbara Birkaya et al.

BMC MOLECULAR BIOLOGY (2007)

Review Immunology

Regulatory T cells, tumour immunity and immunotherapy

WP Zou

NATURE REVIEWS IMMUNOLOGY (2006)

Review Immunology

Cancer immunoediting: from immunosurveillance to tumor escape

GP Dunn et al.

NATURE IMMUNOLOGY (2002)